Step 1 topics → Biochemistry → Ethanol Metabolism

Ethanol Metabolism

USMLE Step 1 trap: Confuses disulfiram's enzyme target with alcohol dehydrogenase instead of aldehyde dehydrogenase. Disulfiram inhibits aldehyde dehydrogenase, causing acetaldehyde accumulation and producing the aversive flushing reaction.

Ethanol metabolism is a high-yield pathway because it creates downstream metabolic chaos — and the exam exploits every branch of that chaos. The core pathway is simple: ethanol → acetaldehyde → acetate, driven by alcohol dehydrogenase (ADH) then aldehyde dehydrogenase (ALDH). Both steps consume NAD+ and produce NADH, and that shift in the NADH/NAD+ ratio is what drives most of the clinical consequences tested on USMLE Step 1. The exam doesn't just ask you to name enzymes — it asks you to reason from an elevated NADH/NAD+ ratio to specific metabolic outcomes like hypoglycemia, lactic acidosis, fatty liver, and hypertriglyceridemia.

The toxic alcohol questions (methanol, ethylene glycol) test a different angle: what happens when you redirect ADH toward a more dangerous substrate? Both methanol and ethylene glycol are metabolized by the same ADH enzyme into products far more toxic than the parent compound. Treatment with fomepizole (or ethanol itself) is based entirely on competitive inhibition of ADH — and USMLE Step 1 loves to test whether you understand that mechanism rather than just memorizing the antidote. Disulfiram adds another layer: it's an ALDH inhibitor, not an ADH inhibitor, and confusing the two is one of the most common errors on this topic.

What makes this topic tricky is that students tend to compartmentalize the facts without building a mechanistic chain. They memorize 'ethanol causes hypoglycemia' but can't explain why — and that's exactly the gap the exam targets. The NADH/NAD+ ratio is the unifying thread: once you internalize how a high NADH/NAD+ ratio shunts metabolic intermediates, the hypoglycemia, lactic acidosis, fatty liver, and hypertriglyceridemia all fall into place as a single mechanistic story instead of a list of disconnected facts.

From real student decks
95%have cards covering this topic
78%have mature cards
1median lapses in 14 days

Well-covered in most decks — the challenge is retention, not exposure.

Common misconceptions

Common mistake
Wrong: Disulfiram inhibits alcohol dehydrogenase, preventing ethanol breakdown.
Right: Disulfiram inhibits aldehyde dehydrogenase, causing acetaldehyde accumulation and producing the aversive flushing reaction.
Disulfiram acts downstream of ADH — it blocks ALDH, the enzyme that converts acetaldehyde to acetate. Because ADH is still fully active, ethanol gets broken down normally to acetaldehyde, which then accumulates to toxic levels and causes the classic flushing, nausea, and tachycardia. If disulfiram blocked ADH instead, ethanol itself would accumulate and the drug's aversive mechanism wouldn't work the way it does clinically.
Common mistake
Wrong: Methanol itself is directly toxic to the optic nerve and causes metabolic acidosis.
Right: Methanol is metabolized by alcohol dehydrogenase to formaldehyde and formic acid, which cause optic nerve toxicity and high anion gap metabolic acidosis.
Methanol itself is relatively inert — it's the metabolites that kill. ADH converts methanol to formaldehyde, which is rapidly converted to formic acid, and formic acid is what directly damages the optic nerve and drives a high anion gap metabolic acidosis. This is why the treatment makes sense: fomepizole blocks ADH, preventing methanol from ever becoming formaldehyde in the first place. If the parent compound were directly toxic, blocking ADH wouldn't help.
Common mistake
Wrong: Ethanol metabolism causes hyperglycemia by stimulating glycogenolysis.
Right: Ethanol metabolism raises the NADH/NAD+ ratio, which inhibits gluconeogenesis (by shunting oxaloacetate and pyruvate toward lactate/malate), causing hypoglycemia.
Ethanol metabolism floods the cell with NADH, raising the NADH/NAD+ ratio. This is the problem: gluconeogenesis requires NAD+ at multiple steps, and the high NADH/NAD+ ratio shunts key gluconeogenic intermediates — oxaloacetate gets converted to malate, and pyruvate gets converted to lactate — draining the substrates needed to make glucose. Glycogen stores are a separate issue; in a fasting alcoholic patient, glycogen may already be depleted, but the primary mechanism of hypoglycemia is the block in gluconeogenesis, not stimulation of glycogenolysis.
Common mistake
Gap: Missing the link between elevated NADH from ethanol metabolism and alcoholic fatty liver/hypertriglyceridemia
The high NADH/NAD+ ratio from ethanol metabolism also promotes fatty acid synthesis and inhibits beta-oxidation, contributing to alcoholic fatty liver and hypertriglyceridemia.
The same NADH overload that blocks gluconeogenesis also impairs beta-oxidation of fatty acids, because beta-oxidation requires NAD+ as an electron acceptor. With beta-oxidation inhibited, fatty acids accumulate in hepatocytes and are re-esterified into triglycerides, producing fatty liver (hepatic steatosis) and driving up serum triglycerides. This is a direct consequence of the NADH/NAD+ imbalance — not a separate process — so it should be part of the same mechanistic chain you reason through whenever you see high NADH from ethanol.
Free Deck audit

See if your Anki deck covers this topic.

Upload your deck →
Guided session

Stuck on this? An AI tutor that probes your understanding.

Start a session →

What the exam tests

  1. Know the two-step enzymatic pathway for ethanol metabolism (ADH then ALDH), and specifically identify that disulfiram inhibits ALDH — causing acetaldehyde accumulation — not ADH.
  2. Given a clinical vignette of methanol or ethylene glycol ingestion, explain that toxicity comes from their metabolites (formaldehyde/formic acid for methanol; oxalic acid/calcium oxalate for ethylene glycol), and recognize that fomepizole works by blocking ADH to prevent formation of those toxic metabolites.
  3. Trace the consequences of a high NADH/NAD+ ratio after ethanol metabolism: inhibition of gluconeogenesis (not glycogenolysis) as the mechanism of hypoglycemia, shunting of pyruvate to lactate causing lactic acidosis, and inhibition of beta-oxidation plus promotion of fatty acid synthesis contributing to alcoholic fatty liver and hypertriglyceridemia.

Can you avoid these mistakes?

A chronic alcoholic is brought to the ED after a 3-day drinking binge without eating. His glucose is 48 mg/dL. What is the primary biochemical mechanism of his hypoglycemia, and which specific metabolic pathway is impaired?
A patient ingests methanol at a party. His labs show a pH of 7.18 and an anion gap of 24. Why does methanol cause a high anion gap metabolic acidosis, and what is the mechanism of action of fomepizole in treating this patient?
A patient on disulfiram therapy drinks alcohol and develops severe flushing, nausea, and palpitations. Which enzyme does disulfiram inhibit, what substance accumulates as a result, and why would disulfiram NOT work if it blocked alcohol dehydrogenase instead?
Explain in one mechanistic chain why chronic ethanol use leads to both hypertriglyceridemia and hepatic steatosis — starting from the NADH/NAD+ ratio and ending at triglyceride accumulation in the liver.

Related topics

Fermentation and NAD+ Regeneration Nucleotide and Nucleic Acid Structure DNA Replication DNA Repair Pathways Mutations and Their Consequences

See how your Anki deck covers this topic.

Upload your deck for a free audit →